BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 11890434)

  • 1. Methodological changes in the evaluation of complementary and alternative medicine: issues raised by Sherman et al. and Hawk et al.
    Redwood D
    J Altern Complement Med; 2002 Feb; 8(1):5-6. PubMed ID: 11890434
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrating qualitative methods in randomized controlled trials: the experience of the Oregon Center for Complementary and Alternative Medicine.
    Vuckovic N
    J Altern Complement Med; 2002 Jun; 8(3):225-7. PubMed ID: 12165180
    [No Abstract]   [Full Text] [Related]  

  • 3. Closing comment: Evidence-based complementary and alternative medicine: is it a viable concept?
    Wilson K; Mills E
    J Altern Complement Med; 2002 Dec; 8(6):875-6. PubMed ID: 12614538
    [No Abstract]   [Full Text] [Related]  

  • 4. Does complementary and alternative medicine represent only placebo therapies?
    Bland J
    Altern Ther Health Med; 2008; 14(2):16-8. PubMed ID: 18383985
    [No Abstract]   [Full Text] [Related]  

  • 5. The Swiss program for the evaluation of complementary medicine (PEK).
    Walach H
    J Altern Complement Med; 2006 Apr; 12(3):231-2. PubMed ID: 16646720
    [No Abstract]   [Full Text] [Related]  

  • 6. New report calls for comprehensive, evidence-based CAM.
    Adv Mind Body Med; 2005; 21(1):33. PubMed ID: 15973857
    [No Abstract]   [Full Text] [Related]  

  • 7. Whole systems research: a discipline for studying complementary and alternative medicine.
    Ritenbaugh C; Verhoef M; Fleishman S; Boon H; Leis A
    Altern Ther Health Med; 2003; 9(4):32-6. PubMed ID: 12868250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intangible principles of good research in complementary and alternative medicine.
    Ernst E
    Altern Ther Health Med; 2002; 8(3):22. PubMed ID: 12017495
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence-based complementary and alternative medicine: back to basics.
    Hammerschlag R; Zwickey H
    J Altern Complement Med; 2006 May; 12(4):349-50. PubMed ID: 16722781
    [No Abstract]   [Full Text] [Related]  

  • 10. Complementary and alternative medicine in outcomes research.
    Riley D; Berman B
    Altern Ther Health Med; 2002; 8(3):36-7. PubMed ID: 12017498
    [No Abstract]   [Full Text] [Related]  

  • 11. n-of-1 randomized controlled trials: an opportunity for complementary and alternative medicine evaluation.
    Johnston BC; Mills E
    J Altern Complement Med; 2004 Dec; 10(6):979-84. PubMed ID: 15673992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blind trial: a subjugation tool.
    Stambolović V
    J Altern Complement Med; 2003 Oct; 9(5):615-7. PubMed ID: 14629838
    [No Abstract]   [Full Text] [Related]  

  • 13. NCCAM: a new plan, new priorities, and an open invitation.
    Straus SE; Chesney MA
    Altern Ther Health Med; 2004; 10(6):16. PubMed ID: 15624345
    [No Abstract]   [Full Text] [Related]  

  • 14. The Institute of Medicine report on complementary and alternative medicine in the United States--personal reflections on its content and implications.
    Eisenberg DM
    Altern Ther Health Med; 2005; 11(3):10-5. PubMed ID: 15943128
    [No Abstract]   [Full Text] [Related]  

  • 15. David Moher, MSc The CONSORT Guidelines: improving the quality of research. Consolidated Standards of Reporting Trials. Interview by Bonnie Horrigan.
    Moher D
    Altern Ther Health Med; 2002; 8(3):103-8. PubMed ID: 12017485
    [No Abstract]   [Full Text] [Related]  

  • 16. Methodological issues and complementary therapies: researching intangibles?
    Carter B
    Complement Ther Nurs Midwifery; 2003 Aug; 9(3):133-9. PubMed ID: 12852929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing the Impact of Randomized, Controlled Trials in Gastrointestinal Endoscopy.
    Elmunzer BJ
    Gastroenterology; 2015 Sep; 149(3):521-5. PubMed ID: 26226569
    [No Abstract]   [Full Text] [Related]  

  • 18. When to disbelieve the believable.
    Riley D; Moher D
    Altern Ther Health Med; 2002; 8(5):36-7. PubMed ID: 12233800
    [No Abstract]   [Full Text] [Related]  

  • 19. Concerns raised over new model guidelines for the use of CAM.
    Blodgett D
    Altern Ther Health Med; 2002; 8(6):18-9; author reply 19. PubMed ID: 12440834
    [No Abstract]   [Full Text] [Related]  

  • 20. New model guidelines for the use of complementary and alternative therapies in medical practice.
    Altern Ther Health Med; 2002; 8(4):44-7, quiz 48, 99. PubMed ID: 12126172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.